Skip to content

Effect of dry cupping and bistort in Women with heavy menstrual bleeding

Efficacy of Hijama bila Shart and Safuf Anjabar in Women with Kathrat-i-Hayd-A Pilot Study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098321
Enrollment
15
Registered
2025-12-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N924- Excessive bleeding in the premenopausal period

Interventions

Intervention1: Anjabar (Polygonium bistorta L.) root and dry cupping: Safuf Anjabar will be pounded, sieved and mixed well to make a homogenous powder. Orally 5g will be given in twice daily for 5 day

Sponsors

National Institute of Unani Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Females aged 18 45 years with regular menstrual cycles (21 35 days) and MBL greater than 80 mL or duration greater than 7 days in at least 2 of 3 consecutive cycles. PBAC score >80 mL in the menstrual pictogram. Thickened endometrium (up to 18 mm), adenomyosis, or up to 3 uterine fibroids (less than 5 cm each). Mild (Hb 11 11.5 g/dL) to moderate (haemoglobin level 8 10.9 g/dL) anemia.

Exclusion criteria

Exclusion criteria: Participants with uncontrolled hypertension (140/90 mmHg), uncontrolled diabetes with FBS 130 mg/dL or PPBS 180 mg/dL or RBS 200 mg/dL or HbA1c 7% more than these values, or uncontrolled hypothyroidism. Participants with bleeding disorders, severe anemia (Haemoglobin level less than 8 g/dL), or malignancy. Use of hormonal contraceptives within the past 3 months. More than 3 uterine fibroids or any fibroid more than 5 cm in size.

Design outcomes

Primary

MeasureTime frame
PBLAC (Pictorial Blood Loss Assessment Chart)Timepoint: After menstruation for three consecutive cycles. After treatment: After menstruation for 1 month (without any intervention).

Secondary

MeasureTime frame
MIQ (Menorrhagia Impact Questionnaire), Haemoglobin percentage, PGATT, PGARTTimepoint: at third follow-up cycle after treatment

Countries

India

Contacts

Public ContactArshiya Sultana

National Institute of Unani Medicine

drarsshiya@yahoo.com09740915911

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026